NCT07341867 2026-01-14Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null PhenotypeDana-Farber Cancer InstitutePhase 1 Not yet recruiting90 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00004036 2013-12-19Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Unknown30 enrolled